List of Excipients in API TRIMIPRAMINE MALEATE
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing TRIMIPRAMINE MALEATE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Epic Pharma LLC | trimipramine maleate | 42806-802 | BUTYL ALCOHOL |
| Epic Pharma LLC | trimipramine maleate | 42806-802 | D&C YELLOW NO. 10 |
| Epic Pharma LLC | trimipramine maleate | 42806-802 | FD&C BLUE NO. 1 |
| Epic Pharma LLC | trimipramine maleate | 42806-802 | FD&C BLUE NO. 2 |
| Epic Pharma LLC | trimipramine maleate | 42806-802 | FD&C RED NO. 40 |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for TRIMIPRAMINE MALEATE
Excipient focus: AMMONIA
TRIMIPRAMINE MALEATE drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | trimipramine maleate | 51991-945 |
| >Company | >Ingredient | >NDC |
TRIMIPRAMINE MALEATE drug variants not containing AMMONIA
Excipient focus: BUTYL ALCOHOL
TRIMIPRAMINE MALEATE drug variants containing BUTYL ALCOHOL
TRIMIPRAMINE MALEATE drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | trimipramine maleate | 51991-945 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 28
TRIMIPRAMINE MALEATE drug variants containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | trimipramine maleate | 51991-945 |
| >Company | >Ingredient | >NDC |
TRIMIPRAMINE MALEATE drug variants not containing D&C RED NO. 28
Excipient focus: D&C YELLOW NO. 10
TRIMIPRAMINE MALEATE drug variants containing D&C YELLOW NO. 10
TRIMIPRAMINE MALEATE drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | trimipramine maleate | 51991-945 |
| Bryant Ranch Prepack | trimipramine maleate | 72162-2063 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
TRIMIPRAMINE MALEATE drug variants containing FD&C BLUE NO. 1
TRIMIPRAMINE MALEATE drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
TRIMIPRAMINE MALEATE drug variants containing FD&C BLUE NO. 2
TRIMIPRAMINE MALEATE drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | trimipramine maleate | 51991-945 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
TRIMIPRAMINE MALEATE drug variants containing FD&C RED NO. 40
TRIMIPRAMINE MALEATE drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | trimipramine maleate | 72162-2063 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
TRIMIPRAMINE MALEATE drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | trimipramine maleate | 51991-945 |
| >Company | >Ingredient | >NDC |
TRIMIPRAMINE MALEATE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERROSOFERRIC OXIDE
TRIMIPRAMINE MALEATE drug variants containing FERROSOFERRIC OXIDE
TRIMIPRAMINE MALEATE drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
TRIMIPRAMINE MALEATE drug variants containing GELATIN
TRIMIPRAMINE MALEATE drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
TRIMIPRAMINE MALEATE drug variants containing LACTOSE MONOHYDRATE
TRIMIPRAMINE MALEATE drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
TRIMIPRAMINE MALEATE drug variants containing MAGNESIUM STEARATE
TRIMIPRAMINE MALEATE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
TRIMIPRAMINE MALEATE drug variants containing PROPYLENE GLYCOL
TRIMIPRAMINE MALEATE drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
TRIMIPRAMINE MALEATE drug variants containing SHELLAC
TRIMIPRAMINE MALEATE drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
TRIMIPRAMINE MALEATE drug variants containing TITANIUM DIOXIDE
TRIMIPRAMINE MALEATE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch